• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米比亚私营部门的抗逆转录病毒治疗。

Antiretroviral treatment in the private sector in Namibia.

作者信息

Van der Veen F, Mugala-Mukungu F, Kangudi M, Feris A, Katjitae I, Colebunders R

机构信息

Department Epidemiology and Social Medicine, University of Antwerpen, Belgium.

出版信息

Int J STD AIDS. 2011 Oct;22(10):577-80. doi: 10.1258/ijsa.2011.010452.

DOI:10.1258/ijsa.2011.010452
PMID:21998178
Abstract

Antiretroviral treatment (ART) has been available in the private sector in Namibia since 1998. National guidelines were developed by the Ministry of Health and clinicians of the public and private sector in 2003 and launched at the start of the public sector ART programme by the Ministry of Health. The Namibian HIV Clinicians Society was established around this period to promote adherence to the national guidelines and to provide comprehensive training for health professionals. To monitor adherence to national ART guidelines, in 2003, the Society requested access to anonymized data on ART dispensing from the medical insurance industry. Dispensing data from all Namibian medical insurance companies were obtained. ART regimens were categorized as recommended (non-nucleoside reverse transcriptase inhibitor-based and boosted protease inhibitor [PI]-based), not recommended (non-boosted PI-based or stavudine/didanosine-containing regimens), ineffective (dual therapy) and second line or salvage regimens. This analysis was repeated in 2004, 2005 and 2008. In 2003, only 2306 adult private patients received ART, of which only 1527 (66%) were recommended regimens. In 2008, 7010 private patients received ART, of which 6372 (91%) were recommended regimens. The private sector covered about 15% of the total number of 46,732 reported ART patients reported in the year 2008. Many of these private patients might not have accessed ART in the public sector.

摘要

自1998年起,纳米比亚的私营部门就已提供抗逆转录病毒治疗(ART)。2003年,纳米比亚卫生部以及公共和私营部门的临床医生制定了国家指南,并由卫生部在公共部门抗逆转录病毒治疗计划启动时予以发布。纳米比亚艾滋病毒临床医生协会大约在这一时期成立,旨在促进对国家指南的遵守,并为卫生专业人员提供全面培训。为监测对国家抗逆转录病毒治疗指南的遵守情况,该协会于2003年请求从医疗保险行业获取抗逆转录病毒治疗配药的匿名数据。获取了纳米比亚所有保险公司的配药数据。抗逆转录病毒治疗方案被分类为推荐方案(基于非核苷类逆转录酶抑制剂和增强型蛋白酶抑制剂[PI])、非推荐方案(基于非增强型PI或含司他夫定/去羟肌苷的方案)、无效方案(二线治疗)以及二线或挽救方案。2004年、2005年和2008年重复了这一分析。2003年,仅有2306名成年私营患者接受了抗逆转录病毒治疗,其中只有1527名(66%)采用的是推荐方案。2008年,7010名私营患者接受了抗逆转录病毒治疗,其中6372名(91%)采用的是推荐方案。2008年报告的46732名接受抗逆转录病毒治疗患者中,私营部门覆盖了约15%。这些私营患者中的许多人可能无法在公共部门获得抗逆转录病毒治疗。

相似文献

1
Antiretroviral treatment in the private sector in Namibia.纳米比亚私营部门的抗逆转录病毒治疗。
Int J STD AIDS. 2011 Oct;22(10):577-80. doi: 10.1258/ijsa.2011.010452.
2
Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.非核苷类逆转录酶抑制剂、蛋白酶抑制剂和拉替拉韦为基础的抗逆转录病毒治疗方案治疗的患者中具有临床意义的药物相互作用的预测因素。
Ann Pharmacother. 2011 Mar;45(3):317-24. doi: 10.1345/aph.1P576. Epub 2011 Mar 8.
3
API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.印度成人抗逆转录病毒治疗使用的API共识指南(API-ART指南)。由印度艾滋病协会认可。
J Assoc Physicians India. 2006 Jan;54:57-74.
4
Protease inhibitor-based antiretroviral therapy in treatment-naive HIV-1-infected patients: the evidence behind the options.基于蛋白酶抑制剂的抗逆转录病毒疗法在初治 HIV-1 感染患者中的应用:各种选择的依据。
J Antimicrob Chemother. 2010 Jun;65(6):1094-9. doi: 10.1093/jac/dkq130. Epub 2010 Apr 23.
5
Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.抗逆转录病毒药物选择对高胆固醇血症事件的影响:核苷类逆转录酶抑制剂主干的作用
HIV Med. 2005 Nov;6(6):396-402. doi: 10.1111/j.1468-1293.2005.00325.x.
6
Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program.南非儿童抗逆转录病毒项目中接受非核苷类逆转录酶抑制剂和蛋白酶抑制剂治疗方案的儿童的两年治疗结果
Pediatr Infect Dis J. 2008 Nov;27(11):993-8. doi: 10.1097/INF.0b013e31817acf7b.
7
National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?资源有限国家的成人抗逆转录病毒治疗国家指南:与2003年世界卫生组织指南的一致性?
AIDS. 2006 Jul 13;20(11):1497-502. doi: 10.1097/01.aids.0000237365.18747.13.
8
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study.三种不同高效抗逆转录病毒疗法方案在原发性病毒学失败时的耐药谱及依从性:一项随机研究中的失败率分析
HIV Med. 2004 Sep;5(5):344-51. doi: 10.1111/j.1468-1293.2004.00233.x.
9
Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.抗逆转录病毒药物使用相关的动脉粥样硬化事件风险与其他原因导致的死亡风险比较。
AIDS. 2006 Oct 3;20(15):1941-50. doi: 10.1097/01.aids.0000247115.81832.a1.
10
Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.资源有限环境下的二线抗逆转录病毒疗法:无国界医生组织的经验
AIDS. 2008 Jul 11;22(11):1305-12. doi: 10.1097/QAD.0b013e3282fa75b9.

引用本文的文献

1
Outcomes of HIV treatment from the private sector in low-income and middle-income countries: a systematic review protocol.中低收入国家私营部门治疗艾滋病的结果:系统评价方案。
BMJ Open. 2020 Jan 8;10(1):e031844. doi: 10.1136/bmjopen-2019-031844.
2
Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.缅甸一项由社区支持的公私合营艾滋病毒治疗项目的留存率和死亡率结果。
J Int AIDS Soc. 2016 Oct 25;19(1):20926. doi: 10.7448/IAS.19.1.20926. eCollection 2016.
3
The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa.
抗逆转录病毒治疗对撒哈拉以南非洲艾滋病毒流行年龄构成的影响。
AIDS. 2012 Jul 31;26 Suppl 1(0 1):S19-30. doi: 10.1097/QAD.0b013e3283558526.